Heasman, J; Kofron M, Wylie C (2000). "Beta-catenin signaling activity dissected in the early Xenopus embryo: a novel antisense approach.". Developmental Biology222 (1): 124–34. PMID10885751. doi:10.1006/dbio.2000.9720.
Summerton, JE (2005). "Endo-porter: a novel reagent for safe, effective delivery of substances into cells.". Ann N Y Acad Sci.1058: 62–75. PMID16394126. doi:10.1196/annals.1359.012.
Coonrod, SA; Bolling LC, Wright PW, Visconti PE, Herr JC (2001). "A morpholino phenocopy of the mouse MOS mutation.". Genesis30 (3): 198–200. PMID11477708. doi:10.1002/gene.1065.
Stancheva, I; Collins AL, Van den Veyver IB, Zoghbi H, Meehan RR (2003). "A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by notch in Xenopus embryos.". Mol Cell12 (2): 425–35. PMID14536082. doi:10.1016/S1097-2765(03)00276-4.
Bruno, IG; Jin W, Cote GJ (2004). "Correction of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements.". Hum Mol Genet3 (20): 2409–20. PMID15333583. doi:10.1093/hmg/ddh272.
Vetrini, F; Tammaro R, Bondanza S, Surace EM, Auricchio A, De Luca M, Ballabio A, Marigo V (2006). "Aberrant splicing in the ocular albinism type 1 gene (OA1/GPR143) is corrected in vitro by morpholino antisense oligonucleotides.". Hum Mutat27 (5): 420–6. PMID16550551. doi:10.1002/humu.20303.
Morcos, PA (2007). "Achieving targeted and quantifiable alteration of mRNA splicing with Morpholino oligos.". Biochem Biophys Res Commun358 (2): 521. PMID17493584. doi:10.1016/j.bbrc.2007.04.172.
König, H; Matter N, Bader R, Thiele W, Müller F (2007). "Splicing Segregation: The Minor Spliceosome Acts outside the Nucleus and Controls Cell Proliferation.". Cell131 (4): 718–29. PMID18022366. doi:10.1016/j.cell.2007.09.043.
Yen, L; Svendsen J, Lee JS, Gray JT, Magnier M, Baba T, D'Amato RJ, Mulligan RC (2004). "Exogenous control of mammalian gene expression through modulation of RNA self-cleavage.". Nature431 (7007): 471–6. PMID15386015. doi:10.1038/nature02844.
Kamachi, Y; Okuda Y, Kondoh H (2008). "Quantitative Assessment of the Knockdown Efficiency of Morpholino Antisense Oligonucleotides in Zebrafish Embryos Using a Luciferase Assay". Genesis46 (1): 1–7. PMID18196596. doi:10.1002/dvg.20361.
Youngblood, DS; Hatlevig SA, Hassinger JN, Iversen PL, Moulton HM (2007). "Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.". Bioconjug Chem.18 (1): 50–60. PMID17226957. doi:10.1021/bc060138s.
Ekker, SC; Larson JD (2001). "Morphant Technology in Model Developmental Systems.". Genesis30 (3): 89–93. PMID11477681. doi:10.1002/gene.1038.
Cerda, GA; Thomas JE, Allende ML, Karlstrom RO, Palma V (2006). "Electroporation of DNA, RNA, and morpholinos into zebrafish embryos.". Methods39 (3): 207–11. PMID16837210. doi:10.1016/j.ymeth.2005.12.009.
Fletcher, S; Honeyman K, Fall AM, Harding PL, Johnsen RD, Wilton SD (2006). "Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide.". J Gene Med.8 (2): 207–16. PMID16285002. doi:10.1002/jgm.838.
Kipshidze, NN; Kim HS, Iversen P, Yazdi HA, Bhargava B, New G, Mehran R, Tio F, Haudenschild C, Dangas G, Stone GW, Iyer S, Roubin GS, Leon MB, Moses JW (2002). "Intramural coronary delivery of advanced antisense oligonucleotides reduces neointimal formation in the porcine stent restenosis model.". J Am Coll Cardiol.39 (10): 1686–91. PMID12020498. doi:10.1016/S0735-1097(02)01830-2.
Abes, S; Moulton HM, Clair P, Prevot P, Youngblood DS, Wu RP, Iversen PL, Lebleu B (2006). "Vectorization of morpholino oligomers by the (R-Ahx-R)(4) peptide allows efficient splicing correction in the absence of endosomolytic agents.". J Control Release116 (3): 304–13. PMID17097177. doi:10.1016/j.jconrel.2006.09.011.
Li, YF; Morcos PA (2008). "Design and Synthesis of Dendritic Molecular Transporter that Achieves Efficient in Vivo Delivery of Morpholino Antisense Oligo.". Bioconjug Chem19 (7): 1464–70. PMID18564870. doi:10.1021/bc8001437.
Summerton, J (1999). "Morpholino Antisense Oligomers: The Case for an RNase-H Independent Structural Type.". Biochimica et Biophysica Acta1489 (1): 141–58. PMID10807004.
Draper, BW; Morcos, PA, Kimmel, CB (2001). "Inhibition of zebrafish fgf8 pre-mRNA splicing with morpholino oligos: A quantifiable method for gene knockdown.". Genesis30 (3): 154–6. PMID11477696. doi:10.1002/gene.1053.
Heasman, J; Kofron M, Wylie C (2000). "Beta-catenin signaling activity dissected in the early Xenopus embryo: a novel antisense approach.". Developmental Biology222 (1): 124–34. PMID10885751. doi:10.1006/dbio.2000.9720.
Howard, EW; Newman LA, Oleksyn DW, Angerer RC, Angerer LM (2001). "SpKrl: a direct target of (beta)-catenin regulation required for endoderm differentiation in sea urchin embryos.". Development128 (3): 365–75. PMID11152635.
Kos, R; Reedy MV, Johnson RL, Erickson CA (2001). "The winged-helix transcription factor FoxD3 is important for establishing the neural crest lineage and repressing melanogenesis in avian embryos.". Development128 (8): 1467–79. PMID11262245.
Summerton, JE (2005). "Endo-porter: a novel reagent for safe, effective delivery of substances into cells.". Ann N Y Acad Sci.1058: 62–75. PMID16394126. doi:10.1196/annals.1359.012.
Coonrod, SA; Bolling LC, Wright PW, Visconti PE, Herr JC (2001). "A morpholino phenocopy of the mouse MOS mutation.". Genesis30 (3): 198–200. PMID11477708. doi:10.1002/gene.1065.
Stancheva, I; Collins AL, Van den Veyver IB, Zoghbi H, Meehan RR (2003). "A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by notch in Xenopus embryos.". Mol Cell12 (2): 425–35. PMID14536082. doi:10.1016/S1097-2765(03)00276-4.
Bruno, IG; Jin W, Cote GJ (2004). "Correction of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements.". Hum Mol Genet3 (20): 2409–20. PMID15333583. doi:10.1093/hmg/ddh272.
Vetrini, F; Tammaro R, Bondanza S, Surace EM, Auricchio A, De Luca M, Ballabio A, Marigo V (2006). "Aberrant splicing in the ocular albinism type 1 gene (OA1/GPR143) is corrected in vitro by morpholino antisense oligonucleotides.". Hum Mutat27 (5): 420–6. PMID16550551. doi:10.1002/humu.20303.
Morcos, PA (2007). "Achieving targeted and quantifiable alteration of mRNA splicing with Morpholino oligos.". Biochem Biophys Res Commun358 (2): 521. PMID17493584. doi:10.1016/j.bbrc.2007.04.172.
König, H; Matter N, Bader R, Thiele W, Müller F (2007). "Splicing Segregation: The Minor Spliceosome Acts outside the Nucleus and Controls Cell Proliferation.". Cell131 (4): 718–29. PMID18022366. doi:10.1016/j.cell.2007.09.043.
Yen, L; Svendsen J, Lee JS, Gray JT, Magnier M, Baba T, D'Amato RJ, Mulligan RC (2004). "Exogenous control of mammalian gene expression through modulation of RNA self-cleavage.". Nature431 (7007): 471–6. PMID15386015. doi:10.1038/nature02844.
Kamachi, Y; Okuda Y, Kondoh H (2008). "Quantitative Assessment of the Knockdown Efficiency of Morpholino Antisense Oligonucleotides in Zebrafish Embryos Using a Luciferase Assay". Genesis46 (1): 1–7. PMID18196596. doi:10.1002/dvg.20361.
Hudziak, RM; Barofsky E, Barofsky DF, Weller DL, Huang SB, Weller DD (1996). "Resistance of morpholino phosphorodiamidate oligomers to enzymatic degradation.". Antisense Nucleic Acid Drug Dev6 (4): 267–72. PMID9012862.
Youngblood, DS; Hatlevig SA, Hassinger JN, Iversen PL, Moulton HM (2007). "Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.". Bioconjug Chem.18 (1): 50–60. PMID17226957. doi:10.1021/bc060138s.
Ekker, SC; Larson JD (2001). "Morphant Technology in Model Developmental Systems.". Genesis30 (3): 89–93. PMID11477681. doi:10.1002/gene.1038.
Cerda, GA; Thomas JE, Allende ML, Karlstrom RO, Palma V (2006). "Electroporation of DNA, RNA, and morpholinos into zebrafish embryos.". Methods39 (3): 207–11. PMID16837210. doi:10.1016/j.ymeth.2005.12.009.
Jubin, R (2004). "Optimizing electroporation conditions for intracellular delivery of morpholino antisense oligonucleotides directed against the hepatitis C virus internal ribosome entry site.". Methods Mol Med.106: 309–22. PMID15375324.
Partridge, M; Vincent A, Matthews P, Puma J, Stein D, Summerton J (1996). "A simple method for delivering morpholino antisense oligos into the cytoplasm of cells.". Antisense Nucleic Acid Drug Dev.6 (3): 169–75. PMID8915501.
Fletcher, S; Honeyman K, Fall AM, Harding PL, Johnsen RD, Wilton SD (2006). "Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide.". J Gene Med.8 (2): 207–16. PMID16285002. doi:10.1002/jgm.838.
Kipshidze, NN; Kim HS, Iversen P, Yazdi HA, Bhargava B, New G, Mehran R, Tio F, Haudenschild C, Dangas G, Stone GW, Iyer S, Roubin GS, Leon MB, Moses JW (2002). "Intramural coronary delivery of advanced antisense oligonucleotides reduces neointimal formation in the porcine stent restenosis model.". J Am Coll Cardiol.39 (10): 1686–91. PMID12020498. doi:10.1016/S0735-1097(02)01830-2.
Abes, S; Moulton HM, Clair P, Prevot P, Youngblood DS, Wu RP, Iversen PL, Lebleu B (2006). "Vectorization of morpholino oligomers by the (R-Ahx-R)(4) peptide allows efficient splicing correction in the absence of endosomolytic agents.". J Control Release116 (3): 304–13. PMID17097177. doi:10.1016/j.jconrel.2006.09.011.
Li, YF; Morcos PA (2008). "Design and Synthesis of Dendritic Molecular Transporter that Achieves Efficient in Vivo Delivery of Morpholino Antisense Oligo.". Bioconjug Chem19 (7): 1464–70. PMID18564870. doi:10.1021/bc8001437.
